Diarrhea in three sets of product information
The US and Canadian figures come from the same two placebo-controlled trials, which the US label numbers Trial 1 and Trial 6 and Canada calls PIONEER 1 and PIONEER 8 [1][3]. Europe pools ten phase 3a trials and gives one percentage for all strengths together [2].
| Source | Placebo | 7 mg | 14 mg |
|---|---|---|---|
| US PI, Table 2 [1] | 4% | 9% | 10% |
| Canadian PM, Table 3 [3] | 4.1% | 8.7% | 10.1% |
| EU SmPC 4.8, ten phase 3a trials [2] | — | “Very common”: 10% across strengths | — |
| EU only: 25 mg and 50 mg, PIONEER PLUS [2] | — | 13% on 25 mg | 14% on 50 mg |
Who the trial numbers describe
Across the two pooled trials, 1,071 adults with type 2 diabetes took the tablets for an average of 41.8 weeks. Their mean age was 58, 3.9% were 75 or older, and they had had diabetes for about 9.4 years. Kidney function at the start was normal in 66.2%, mildly reduced in 32.4% and moderately reduced in only 1.4% [1].
That matters for a symptom tied to fluid loss. A separate 26-week study, Trial 5, enrolled 324 adults with moderate kidney impairment and a mean age of 70, but the label prints no diarrhea rate from it [1]. The recommended dose is the same with reduced kidney function, and no overall safety difference was seen between people aged 65 and over and younger adults [1].
Flat between the two strengths
Diarrhea more than doubled from placebo to 7 mg, then rose by about one point at 14 mg [1]. Nausea in the same table almost doubled between the strengths, so the two symptoms do not move together. With roughly 356 people per group, a one-point gap is too small to read much into.
Each figure counts people who had diarrhea at least once during months of treatment, not how many days it lasted. The label says most reports of diarrhea, nausea and vomiting came while the dose was rising [1]. Europe describes most digestive events as mild to moderate, short and most frequent in the first months [2], and the Canadian leaflet says diarrhea usually goes away with time [3].
What patient reports show
A 2024 study combined US FDA adverse-event reports with patient reviews posted on two health websites, covering semaglutide tablets and injections together. In the reviews, diarrhea was the second most mentioned problem after nausea, with 129 mentions; in the FDA database it was the third most reported term, with 1,822 reports [4].
Neither source can say how often diarrhea happens on Rybelsus®. Reviews are written by people who choose to post, FDA reports are voluntary, and neither proves that the medicine caused the symptom [4].
Why it may happen
- From the labels: digestive reactions are more common on semaglutide tablets than on placebo, and the gradual start is designed to reduce them [1]. The labels describe slowed stomach emptying but do not explain diarrhea specifically.
- Linked to exposure: Canada reports more digestive events in women and in people with lower body weight, who had higher levels of semaglutide [3].
- General causes that can add up: NIH lists some antacids that contain magnesium, antibiotics and sugar alcohols such as sorbitol or xylitol among causes of acute diarrhea [5]. These are not studied in Rybelsus® users.
Other causes worth considering
According to NIH, the most common causes of sudden diarrhea are viral stomach infections, food poisoning and medicine side effects [5]. Diarrhea that lingers can come from lactose, fructose or sugar intolerance, coeliac disease, Crohn’s disease or ulcerative colitis, irritable bowel syndrome, pancreas problems, earlier surgery on the gallbladder or bowel, and nerve damage from diabetes [5]. Long courses of antibiotics can also lead to a C. difficile infection [5].
Fluids, rehydration and over-the-counter options
The Medication Guide links diarrhea, nausea and vomiting to fluid loss that can cause kidney problems, and says drinking fluids lowers the chance of dehydration [1]. NIH suggests water and liquids with electrolytes such as broth or sports drinks, and returning to a normal diet once appetite comes back [6]. It adds that people with diabetes, kidney disease or a weak immune system, and older adults, should ask a doctor before using oral rehydration solutions, because a particular solution or amount may suit them better [6].
NIH notes that loperamide and bismuth subsalicylate are sold over the counter for short bouts, but not for people with bloody stools or a fever, and that a doctor should be seen if diarrhea worsens or lasts more than two days on them [6]. Ask a pharmacist first, tell your prescriber about any medicine you add [1], and keep other tablets at least 30 minutes after Rybelsus® [1].
Rybelsus® and Ozempic® are registered trademarks of Novo Nordisk A/S. PepLabo is not affiliated with or endorsed by Novo Nordisk.
When to get help
| Sign | Who to contact | How fast | Source |
|---|---|---|---|
| Severe stomach pain that will not go away, with or without diarrhea or vomiting | Stop Rybelsus® and call your provider right away | Emergency | Rybelsus® Medication Guide [1] |
| Black, tarry stools, or stools with red blood or pus | A doctor right away | Today | NIDDK [5] |
| Confusion or unusual lack of energy, frequent vomiting or signs of dehydration | A doctor right away | Today | NIDDK [5] |
| Diarrhea for more than 2 days, a high fever or six or more loose stools a day | A doctor right away | Today | NIDDK [5] |
| Diarrhea that does not go away | Your prescriber, right away | Today | Rybelsus® Medication Guide [1] |
| Diarrhea that comes and goes but bothers you | Your prescriber at your next visit | At your next appointment | Rybelsus® Medication Guide [1] |
